Compound details
Thonningine A
| Compound ID | CDAMM00886 |
|---|---|
| Common name | Thonningine A | IUPAC name | 6-(1,3-benzodioxol-5-yl)-5-hydroxy-4,9-dimethoxy-2-prop-1-en-2-ylfuro[3,2-g]chromen-7-one |
| Molecular formula | C23H18O8 |
| Retention time | 0.27 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 423.106 | Theoretical mz | 423.107 |
| Error | 3.02 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.3423 |
| Inchi key | DHHUFQCTMOFVTD-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C1OC=2C(OC)=C3OC(=CC3=C(OC)C2C(O)=C1C=4C=CC=5OCOC5C4)C(=C)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | Coumarins and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| P49759 | CLK1 | Dual specificty protein kinase CLK1 | T46685 | SEA |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | T82720 | SEA |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SEA |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SEA |
| P49760 | CLK2 | Dual specificity protein kinase CLK2 | T73725 | SEA |
| P49761 | CLK3 | Dual specificity protein kinase CLK3 | T21585 | SEA |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SEA |
| P35557 | GCK | Hexokinase type IV | T87166 | SwissTargetPrediction |
| P19438 | TNFRSF1A | Tumor necrosis factor receptor R1 | T86552 | SEA |
| H3BPQ1 | TCF4 | Transcription factor 7-like 2 | T54646 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T87166 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P35557 | GCK |
| T87166 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P35557 | GCK |
| T87166 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P35557 | GCK |
| T87166 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P35557 | GCK |
| T86552 | DI0060 | Brain cancer | [ICD-11: 2A00] | P19438 | TNFRSF1A |
| T86552 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P19438 | TNFRSF1A |